| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Branding > Apple Gets Sued Over The iPhone |
|
Digg It - Apple Gets Sued Over The iPhone
Many people wondered how Apple managed to gain the rights to use the name iPhone from Cisco Syste According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ms who have trademarked the name. Apparently Apple doesn’t actually own the rights to the name iP ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in one, but they went ahead with their huge launch regardless. The real owners of the name, Cisco Sy lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. stems, are suing Apple for making free use of a name they have already trademarked. This could sp here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ll a large amount of trouble for Steve Jobs and the Apple clan if this suite is won by Cisco. Job d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro s has stated that he believes that Cisco won’t be able to uphold their claim “because other produ ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ts have already been released with that name.” It’s almost a case of; well, everyone else is doin easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi g this so why can’t we? There may very well be other products out there labelled iPhone, but App nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e has made the biggest splash with theirs. They shouldn’t be surprised that they are targeted by and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ Cisco. What surprised me is that Apple went ahead with the unveiling while the name was still uns ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi cured. Why put an entire marketing campaign at risk because you can’t set up the groundwork prope ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ly? That’s bad enough, but for it to be justified by a childish response like they used is inexcu dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod sable for such a huge corporation. The revelation may also show Apple and the iPhone in a bad lig cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin t to many consumers, but whether that makes a difference to sales is yet to be seen. Did the guy tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen s at Apple really expect to get away with it after the huge amount of publicity they drummed up b t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel such a public unveiling of the product? Particularly since the Linksys division of Cisco Systems ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust recently released their own iPhone product. The products may be widely divergent, but only one o y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products them will get the universal brand recognition that comes with the name. Regardless of the fact t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de hat one is a VOIP product and the other is the new every function phone. The people who gain the elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip enefit from the recognition should be the people who legitimately have the right to use that name tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Is A High Security Paper Shredder Right For Your Business? Student Business: Why You Should Jump on the Opportunity Embroidering on Women's Apparel
|